EMRA*Cast

It happens overnight: You go from being a trainee to working as an attending – and the senior-level confidence you felt just 24 hours earlier can't even be spotted with the donut of truth. What's a new attending to do? 
In her final episode as an EMRA*Cast fellow, host Blythe Fiscella, MD, shares a hodgepodge of actionable advice from EM attendings as she transitions from residency to starting as an attending at the same institution.

A seemingly routine pediatric nosebleed quickly became one of the most frightening cases of my career when a five-year-old with undiagnosed immune thrombocytopenia (ITP) developed life-threatening epistaxis. In this episode, we walk through the case and explore why dissolvable hemostatic agents may be an underutilized first-line option, incorporating insights from ENT that may change your practice the next time pressure, Afrin, and traditional packing fail.

In this solo episode, Dr. Blythe Fiscella shares 11 hard-won lessons from the emergency department — covering everything from procedures and airway management to communication and clinical uncertainty. Whether you're a resident or a seasoned clinician, there's something here for everyone.

In this mini episode of our "Bridging Health and Humanity" series on EMRA*Cast, Dr. Natalie Hernandez speaks with EM:RAP's Dr. Matt Delaney about patient vulnerability during transitions of care, focusing on what clinicians should do when receiving sign-out.

The opioid epidemic has become supercharged in the past 10-15 years, first with the widespread replacement of heroin by the more potent fentanyl and more recently with the introduction of alpha agonists such as xylazine and medetomidine into the drug supply. Peter Lorenz, MD, sits down with EM/tox/addiction medicine-trained Rachel Haroz, MD, to discuss this ever-changing landscape and how to best provide lifesaving care to some of our most vulnerable patients in the emergency department.